首页> 外文期刊>Therapeutic Drug Monitoring >A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry
【24h】

A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry

机译:一种直接监测人血管疾病预防的阿托伐他汀粘附性的方法:使用2通道色谱法和串联质谱法定量母体药物和主要代谢物的总暴露

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Low adherence to statin therapy remains a public health concern associated with poor prognosis in cardiovascular disease patients. A feasible method for statin adherence monitoring in clinical practice has yet to be developed. In this article, we describe a novel method designed for the direct monitoring of atorvastatin adherence based on the sum of parent drug and major metabolites in blood samples.
机译:背景:对他汀类药物治疗的低粘附性仍然是一种与心血管疾病患者的预后差有关的公共卫生关注。 临床实践中汀类药物依从性监测的可行方法尚未开发。 在本文中,我们描述了一种新颖的方法,该方法是基于母体药物和血液样本中的主要代谢物的总和直接监测阿托伐他汀粘附。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号